GSK’s Consumer Health Unit Working With Mammoth Biosciences To Develop CRISPR-Based Coronavirus Test

Reuters (5/20, Mishra) reports GlaxoSmithKline (GSK)’s “consumer health unit has tied up with Mammoth Biosciences to develop a test that uses” CRISPR gene editing technology “to detect novel coronavirus infections” by consumers in a home setting. Still, “...